VivoSim Labs, Inc. Form 425: Prospectus or communication for a business combination
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-04-08: Form 425; Description 8-K; Document onvo-8k_20200407.htm.
- 2020-04-01: Form 425; Description 425; Document onvo-425.htm.
- 2020-04-01: Form 425; Description 425; Document onvo-425.htm.
- 2020-04-01: Form 425; Description 8-K; Document onvo-8k_20200331.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-04-08 | 425 | 8-K | onvo-8k_20200407.htm | |
| 2020-04-01 | 425 | 425 | onvo-425.htm | |
| 2020-04-01 | 425 | 425 | onvo-425.htm | |
| 2020-04-01 | 425 | 8-K | onvo-8k_20200331.htm | |
| 2020-03-27 | 425 | 8-K | onvo-8k_20200326.htm | |
| 2020-03-20 | 425 | 425 | d865949d425.htm | |
| 2020-03-20 | 425 | 8-K | d865943d8k.htm | |
| 2020-03-16 | 425 | 425 | d825250d425.htm | |
| 2020-03-16 | 425 | 425 | d825159d425.htm | |
| 2020-03-03 | 425 | 425 | d895290d425.htm | |
| 2020-02-26 | 425 | 425 | d892938d425.htm | |
| 2020-02-26 | 425 | 425 | d857805d425.htm | |
| 2020-01-29 | 425 | 8-K | d842997d8k.htm | |
| 2019-12-30 | 425 | 8-K | d857456d8k.htm | |
| 2019-12-16 | 425 | 8-K | d845871d8k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |